151 DETROIT STREET,
DENVER , CO, 80206
DENVER , CO, 80206
Summary
The fund seeks to replicate the total return performance of the benchmark index, before fees and expenses, by investing in small-and mid-size companies in the United States.
The investment process starts with a list of companies in the benchmark index and the research team utilizes quantitative techniques and fundamental analysis to identify investment opportunities.
Next, the research team invests significantly in the secu More
Webiste
Directors
Jan 12, 2024- Jeffrey B. Weeden
- Carrie Benz
- Clifford J. Weber
- Maureen T. Upton
Chief Compliance Officer
- Kristin Mariani
Price
- $ 80.81 ( -2.11 )
-
Dec 09, 2024Last Close
- Net Assets
-
$313.4M
Mar 21, 2024
- 52-Week High/Low
- $82.8 - $64.5
- Expense Ratio
- -
Performance
YTD
0%
3 Year
22.57%
5 Year
71.86%
Best
543.97%
2000
Worst
-27.31%
2008
Company Name |
Holding |
Incyte Corp. | 2.86 % |
Neurocrine Biosciences, Inc. | 2.78 % |
AppLovin Corp. | 2.69 % |
HEICO Corp. | 2.67 % |
Bio-Techne Corp. | 2.51 % |
Charles River Laboratories International, Inc. | 2.45 % |
Medpace Holdings, Inc. | 2.31 % |
Bentley Systems, Inc. | 2.25 % |
Rollins, Inc. | 2.12 % |
Bruker Corp. | 1.94 % |
More | 1.94 % |
NAV
2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
JSMD | 0% | 1.6% | 26.2% | -23.1% | 8.3% | 29.9% | 30.8% | -4.7% | 24.5% | 98.1% | |
S&P 500 | 1.9% | 23.3% | 24.2% | -19.4% | 27.3% | 16.2% | 28.9% | -6.2% | 19.4% | 9.5% |
2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
q1 | 0% | 6.5% | 7.8% | -10% | 7.1% | -25.8% | 16% | 3.7% | 4.3% | 0% | ||||
q2 | 0% | -4.3% | 10.7% | -16.5% | 1% | 33.4% | 3.6% | 9.3% | 5% | 2.8% | ||||
q3 | 0% | 0% | -6% | -3.9% | -4% | 8.3% | -3.7% | 8.5% | 4.5% | 7.1% | ||||
q4 | 0% | 0% | 13.5% | 6.4% | 4.5% | 21.2% | 10% | -19% | 8.1% | 5.7% |
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025 | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
2024 | -2.1% | 4.6% | 4% | -6.3% | 1.9% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |